Synthesis of 1,2,3-Triazole Derivatives and Evaluation of their Anticancer Activity
Ivan Franko National University of Lviv, Kyryla & Mefodiya Str., 6, 79005 Lviv, Ukraine
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2013, 81(3), 663-676; https://doi.org/10.3797/scipharm.1302-04
Submission received: 8 February 2013
/
Accepted: 14 April 2013
/
Published: 14 April 2013
Abstract
Anticancer screening of several 1,2,3-triazoles with heterocyclic fragments has been performed. The 1,2,3-triazole derivatives were synthesized from available starting materials according to convenient synthetic procedures. The antitumor activity of the synthesized compounds was tested in vitro by the National Cancer Institute in NCI60 cell lines. It was observed that some compounds showed slight anticancer activity. One of them possessed a moderate activity against melanoma, colon, and breast cancer. Standard COMPARE analysis was performed at the GI50 level.
Share and Cite
MDPI and ACS Style
POKHODYLO, N.; SHYYKA, O.; MATIYCHUK, V. Synthesis of 1,2,3-Triazole Derivatives and Evaluation of their Anticancer Activity. Sci. Pharm. 2013, 81, 663-676. https://doi.org/10.3797/scipharm.1302-04
AMA Style
POKHODYLO N, SHYYKA O, MATIYCHUK V. Synthesis of 1,2,3-Triazole Derivatives and Evaluation of their Anticancer Activity. Scientia Pharmaceutica. 2013; 81(3):663-676. https://doi.org/10.3797/scipharm.1302-04
Chicago/Turabian StylePOKHODYLO, Nazariy, Olga SHYYKA, and Vasyl MATIYCHUK. 2013. "Synthesis of 1,2,3-Triazole Derivatives and Evaluation of their Anticancer Activity" Scientia Pharmaceutica 81, no. 3: 663-676. https://doi.org/10.3797/scipharm.1302-04
